DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Goudar RK, Shi Q, Hjelmeland MD, Keir ST, MacLendon RE, Wikstrand CJ, Reese ED, Conrad CA, Traxler P, Lane HA, Reardon DA, Cavenee WK, Wang XF, Bigner DD, Friedman HS, Rich JN.
Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition.
Mol Cancer Ther 2005; 4: 101-112
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.